PERALDO NEIA, CATERINA
 Distribuzione geografica
Continente #
NA - Nord America 660
EU - Europa 260
AS - Asia 182
OC - Oceania 3
SA - Sud America 3
AF - Africa 2
Totale 1.110
Nazione #
US - Stati Uniti d'America 654
CN - Cina 110
IT - Italia 79
IE - Irlanda 42
FI - Finlandia 22
FR - Francia 22
VN - Vietnam 22
SE - Svezia 21
SG - Singapore 21
DE - Germania 20
PL - Polonia 14
KR - Corea 11
GB - Regno Unito 9
BE - Belgio 7
RU - Federazione Russa 7
CA - Canada 6
UA - Ucraina 6
IN - India 4
NL - Olanda 4
AU - Australia 3
HK - Hong Kong 3
CH - Svizzera 2
CL - Cile 2
ES - Italia 2
ID - Indonesia 2
JP - Giappone 2
NG - Nigeria 2
BR - Brasile 1
BT - Bhutan 1
GR - Grecia 1
IR - Iran 1
MY - Malesia 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TR - Turchia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 1.110
Città #
Chandler 127
Beijing 55
Fairfield 49
Dublin 42
Ann Arbor 38
Ashburn 37
Houston 37
Woodbridge 30
Seattle 24
Cambridge 20
Pisa 20
Dearborn 19
Nyköping 19
Torino 19
Dong Ket 17
Wilmington 17
Villeurbanne 16
Warsaw 14
Medford 13
Shanghai 13
Princeton 12
Singapore 12
Munich 11
Turin 9
Jacksonville 8
Brussels 7
Chengdu 5
Hangzhou 5
Nanjing 5
Guangzhou 4
Los Angeles 4
Milan 4
New York 4
Phoenix 4
Boston 3
Hong Kong 3
Abuja 2
Bengaluru 2
Boardman 2
Capriate San Gervasio 2
Catania 2
Cuneo 2
Hefei 2
Menlo Park 2
Ningbo 2
Québec 2
San Michele Mondovì 2
Toronto 2
Tula 2
Abbiategrasso 1
Barcelona 1
Bern 1
Blackpool 1
Bratislava 1
Buffalo 1
Burlington 1
Canberra 1
Charlotte 1
Chicago 1
Civitavecchia 1
Columbus 1
Edinburgh 1
Farmington 1
Fort Wayne 1
Franklin 1
Freiburg 1
Fremont 1
Gaithersburg 1
Grugliasco 1
Helsinki 1
Jakarta 1
Jiaxing 1
Jinan 1
Kharkov 1
Kunming 1
La Jolla 1
Latrobe 1
Littleton 1
London 1
Maastricht 1
Madrid 1
Montreal 1
Montréal 1
Mount Kisco 1
Mountain View 1
Muttenz 1
Naaldwijk 1
Nanchang 1
Norwalk 1
Orlando 1
Paris 1
Perm 1
Portland 1
Redmond 1
Redwood City 1
Reston 1
Rochester 1
Rome 1
Salt Lake City 1
San Mateo 1
Totale 803
Nome #
Potential biomarkers of long-term benefit from single-agent trastuzumab or lapatinib in HER2-positive metastatic breast cancer 153
Preclinical activity of EGFR and MEK1/2 inhibitors in the treatment of biliary tract carcinoma 142
Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models. 140
Establishment of a patient-derived intrahepatic cholangiocarcinoma xenograft model with KRAS mutation. 116
Transcriptomic analysis and mutational status of IDH1 in paired primary-recurrent intrahepatic cholangiocarcinoma 115
Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas 102
Antitumor activity of Src inhibitor Saracatinib (AZD-0530) in preclinical models of biliary tract carcinomas. 80
Screening for the FIG-ROS1 fusion in biliary tract carcinomas by nested PCR. 73
Establishment and characterization of a human intrahepatic cholangiocarcinoma cell line derived from an Italian patient 72
Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer. 69
A new pro-apoptotic therapy for Acute Myeloid Leukaemia using MEDS433, a potent human Dihydroorotate Dehydrogenase inhibitor 64
Fluoropyrimidine‑induced cardiotoxicity in colorectal cancer patients: a prospective observational trial (CHECKPOINT) 18
Totale 1.144
Categoria #
all - tutte 3.216
article - articoli 0
book - libri 0
conference - conferenze 381
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.597


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020186 8 12 8 30 13 26 25 16 9 23 12 4
2020/2021110 7 4 8 9 2 10 8 6 11 12 3 30
2021/2022155 11 14 8 14 3 1 3 4 0 8 54 35
2022/2023281 33 35 7 31 18 71 17 13 28 6 18 4
2023/2024122 12 24 5 7 6 13 4 12 0 9 16 14
Totale 1.144